Rivaroxaban News and Research

RSS
Delayed anticoagulation treatment for atrial fibrillation patients increases dementia risk, study finds

Delayed anticoagulation treatment for atrial fibrillation patients increases dementia risk, study finds

Study finds increased heart attack risk in patients taking direct acting oral anticoagulants

Study finds increased heart attack risk in patients taking direct acting oral anticoagulants

Researchers develop portable sensor for fast, accurate assessment of blood's clotting ability

Researchers develop portable sensor for fast, accurate assessment of blood's clotting ability

New treatment strategy effective in preventing bleeding in AF patients who underwent PCI, study shows

New treatment strategy effective in preventing bleeding in AF patients who underwent PCI, study shows

Novel antidote effective in quickly reversing acute anticoagulant-related bleeding

Novel antidote effective in quickly reversing acute anticoagulant-related bleeding

New oral anticoagulants offer same stroke prevention, but cause less intracranial bleeding than warfarin

New oral anticoagulants offer same stroke prevention, but cause less intracranial bleeding than warfarin

NOACs match warfarin for atrial fibrillation

NOACs match warfarin for atrial fibrillation

New oral blood thinners can decrease stroke risk in atrial fibrillation patients without frequent monitoring

New oral blood thinners can decrease stroke risk in atrial fibrillation patients without frequent monitoring

Women suffering from blood clots can safely take hormone replacement therapy with anticoagulants

Women suffering from blood clots can safely take hormone replacement therapy with anticoagulants

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

New data validates use of ActiveCare DVT prophylaxis compression system following total joint replacement surgery

New data validates use of ActiveCare DVT prophylaxis compression system following total joint replacement surgery

Primary care physicians often under- or over-estimate stroke and bleeding risk in AF patients

Primary care physicians often under- or over-estimate stroke and bleeding risk in AF patients

AF patients treated with rivaroxaban for stroke prevention experience low rates of bleeding and stroke

AF patients treated with rivaroxaban for stroke prevention experience low rates of bleeding and stroke

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Normal coagulation tests used to check for side effect of internal bleeding may not be reliable

Normal coagulation tests used to check for side effect of internal bleeding may not be reliable

Instrumentation Laboratory announces European release of HemosIL Rivaroxaban Testing Solution

Instrumentation Laboratory announces European release of HemosIL Rivaroxaban Testing Solution

More people turn to popular new blood thinners for atrial fibrillation treatment

More people turn to popular new blood thinners for atrial fibrillation treatment

Alternative approach to treat fatal blood clots found to be more effective in patients

Alternative approach to treat fatal blood clots found to be more effective in patients

Newer anticoagulant medication may increase risk of GI bleeding in older patients

Newer anticoagulant medication may increase risk of GI bleeding in older patients

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer